11-101-3026
Irbesartan Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 138402-11-6
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-3026-Each-of-1 | In Stock | ₹ 12,282.00 |
11-101-3026 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 12,282.00
GST (18%): ₹ 2,210.76
Total Price: ₹ 14,492.76
CAS
138402-11-6
Type
Certified Reference Material
Linear Formula
C25H28N6 O
Synonym
2-Butyl-3-[[2′-(2 H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4 ]non-1-en-4-one
Grade
Certified Reference Material
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
MDL Number
MFCD00864464
Formula Weight
428.53
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Apexbio Technology LLC Irbesartan, 100mg. Cas: 138402-11-6 MFCD: MFCD00864464. Angiotensin II inhibitor | -- | ₹ 15,575.00 | ||
Tocris Bioscience™ Irbesartan | -- | ₹ 11,872.60 | ||
eMolecules Ambeed / 3-((2-(1H-Tetrazol-5-yl)-[11-biphenyl]-4-yl)methyl)-2-butyl-13-diazaspiro[4.4]non-1-en-4-one / 5g / 552682577 / A262974 / / 138402-11-6 / MFCD18384966 / 428.540 / C25H28N6O | -- | ₹ 2,604.14 | ||
Sigma Aldrich Fine Chemicals Biosciences Irbesartan British Pharmacopoeia (BP) Reference Standard | 138402-11-6 | MFCD00864464 | | -- | ₹ 28,674.02 | ||
Sigma Aldrich Fine Chemicals Biosciences Irbesartan European Pharmacopoeia (EP) Reference Standard | 138402-11-6 | MFCD00864464 | | -- | ₹ 16,681.27 | ||
Biotang Inc Irbesartan, (Avapro) > 99%, 10MG, CAS#138402-11-6, M.W.428.53, SYON:BMS-186295, SR-47436. RI004-10MG | -- | ₹ 11,699.94 | ||
Irbesartan | -- | ₹ 10,911.60 | ||
Irbesartan | -- | ₹ 14,072.50 | ||
Irbesartan | -- | ₹ 23,944.90 |
Related Products
Description
- Irbesartan is a potent, long-acting 'sartan' class, nonpeptide, angiotensin II receptor antagonist utilized for the management of hypertension as well as heart failure in clinical patients
- It shows high selectivity for the AT1 subtype (angiotensin I), and effectively reduces the probabilities of cardiac failure, myocardial infarction, sudden death, etc.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Featured Industries: Pharmaceutical (small molecule)